Copyright: ©Author(s) 2026.
World J Psychiatry. Sep 19, 2026; 16(9): 120241
Published online Sep 19, 2026. doi: 10.5498/wjp.120241
Published online Sep 19, 2026. doi: 10.5498/wjp.120241
| TCM modality | Target clinical context (metabolic-psychiatric focus) | Intervention use (typical delivery) | Outcomes commonly captured | Dual-endpoint capture1 | Evidence maturity and key limitations |
| Chinese herbal medicine | Depressive symptoms in patients with cardiometabolic comorbidity; adjunctive care when tolerability/acceptability is a concern | Pattern-informed prescriptions; monotherapy or adjunct to antidepressants | Mental health: Depressive symptoms, anxiety, sleep-related complaints; metabolic: Often absent or secondary | Inconsistent (mental-health-dominant in many trials) | Evidence base includes syntheses and condition-specific reviews; limitations: Formulation heterogeneity, variable standardisation, limited integrated metabolic endpoints |
| Acupuncture/EA (PCOS-focused) | PCOS with negative emotions plus metabolic features (weight/insulin resistance concerns) | Protocol-based acupuncture/EA; often alongside lifestyle/usual care | Mental health: Depression/anxiety; metabolic/PCOS: Weight-related and PCOS clinical features commonly reported | More consistent (mood + metabolic/PCOS features often co-reported) | Recent synthesis suggests potential benefit for negative emotions; limitations: Trial quality and heterogeneity; psychiatric endpoints not always primary[106] |
| Acupuncture for insomnia (sleep as a mechanistic amplifier) | Insomnia (often coexisting with metabolic disorders), targeting the sleep-stress-metabolic loop | Manual acupuncture; protocol-driven courses; sometimes adjunct to CBT-I/usual care | Sleep: PSQI/ISI and daytime function; mental health: Mood may be secondary; metabolic: Seldom captured | Partial (sleep-centric; metabolic endpoints uncommon) | Systematic reviews support insomnia improvement; limitation: Integrated metabolic-psychiatric cohorts and dual-endpoint designs remain limited[107] |
| Mind-body therapies (Tai Chi/Qigong) | Adults at risk of MetS/obesity-related risk with psychological distress or reduced self-efficacy | Group-based, adherence-friendly programmes; combined physical + meditative components | Psychosocial: Depressive mood/anxiety, self-efficacy, quality of life; metabolic: Cardiometabolic risk indicators often assessed | Often yes (psychosocial + metabolic outcomes co-reported) | Systematic reviews in MetS-risk populations support multidomain benefits; limitations: Programme heterogeneity, comparator variability, adherence reporting[107] |
| EA for anxiety/depression (general psychiatric target with metabolic relevance via stress axis) | Anxiety/depressive symptoms where stress biology and autonomic dysregulation are prominent (metabolic impact often indirect) | EA protocols; adjunct to standard care | Mental health: Anxiety/depression; metabolic: Typically not collected | Rare (psychiatric endpoint-dominant) | Evidence from systematic reviews exists; limitation: Metabolic outcomes and psychotropic–metabolic stewardship endpoints are rarely incorporated |
| TCM-integrated lifestyle counselling (TCM-informed diet/exercise guidance) | Prediabetes/metabolic risk states where behavior change is central and psychological burden may affect adherence | Individualised counselling aligned with constitution/pattern concepts; pragmatic delivery | Metabolic: Lifestyle adherence and metabolic risk markers; mental health: Usually under-measured | Usually no | Evidence supports metabolic prevention approaches, but dual-endpoint capture and standardized mental-health assessment are uncommon (gap aligns with Figure 2)[108] |
- Citation: Yan M, Yang H, Cui D, Zhang YS. Endocrine psychiatric comorbidity in metabolic disorders: Integrative mechanisms and traditional Chinese medicine. World J Psychiatry 2026; 16(9): 120241
- URL: https://www.wjgnet.com/2220-3206/full/v16/i9/120241.htm
- DOI: https://dx.doi.org/10.5498/wjp.120241